A Study of LDE255 in Combination With Azacitidine for High Risk Myelodysplastic Syndrome Patients

Femme et Homme

| Pays :
| Organes :
| Spécialités :

Extrait

This study is a phase Ib add-on study of the combination of LDE255 to azacitidine in patients without marrow response after at least 6 cycles of azacitidine.

Critère d'inclusion

Liens

ictrp
nct